Currently out of the existing stock ratings of Edward Woo, 339 are a BUY (96.03%), 11 are a HOLD (3.12%), 3 are a SELL (0.85%).

Edward Woo

Work Performance Price Targets & Ratings Chart

Analyst Edward Woo, currently employed at ASCENDIANT, carries an average stock price target met ratio of 50.71% that have a potential upside of 55.16% achieved within 360 days.

Edward Woo’s has documented 623 price targets and ratings displayed on 51 stocks. The coverage is on Healthcare, Communication Services, Consumer Cyclical, Energy, Technology sectors.

Most recent stock forecast was given on DUOT, Duos Technologies Group.

Wall Street Analyst Edward Woo

Analyst best performing recommendations are on HSCS (HEART TEST LABORATORIES COMMON STOCK).
The best stock recommendation documented was for BSGM (BIOSIG TECHNOLOGIES, COMMON STOCK) at 4/21/2025. The price target of $2.5 was fulfilled within 22 days with a profit of $1.97 (371.7%) receiving and performance score of 168.95.

Average potential price target upside

of $384.99 (20.65%) on BKNG (BOOKING HOLDINGS).
of $39.47 (89.57%) on IMAC (IMAC HOLDINGS).
of $33.23 (22.65%) on TTWO (TAKE-TWO INTERACTIVE SOFTWARE).

ATOS Atossa Genetics ATVI Activision Blizzard BIOL BIOLASE BKNG Booking Holdings EA Electronic Arts ENSV Enservco Co EXPE Expedia Group GME GameStop Corp GNSS Genasys GRPN Groupon JAKK JAKKS Pacific MYO Myomo NBY NovaBay Pharmaceuticals NDRA ENDRA Life Sciences OTLK OUTLOOK THERAPEUTICS INC PCOM Points International Ltd. PHUN Phunware PSTV Plus Therapeutics SINT SINTX Technologies TRIP TripAdvisor TTWO Take-Two Interactive Software TZOO Travelzoo VERB VERB TECHNOLOGY COMPANY INC WISA WiSA Technologies AUTO Autoweb LUCD Lucid Diagnostics IMAC Imac Holdings PAVM PAVmed SURG Surgepays VVOS Vivos Therapeutics INTZ Intrusion NRXP NRX Pharmaceuticals HSCS Heart Test Laboratories Common Stock AMTX Aemetis SOPA Society Pass RNXT RenovoRx BSGM BioSig Technologies, Common Stock ALZN Alzamend Neuro BLBX Blackboxstocks CING Cingulate COCH Envoy Medical DUOT Duos Technologies Group DXR Daxor GRI GRI Bio AIM AIM ImmunoTech RDHL Redhill Biopharma Ltd AYTU Aytu BioScience ALLR Allarity Therapeutics EVOK Evoke Pharma GHSI Guardion Health Sciences ISR IsoRay

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Edward Woo (ASCENDIANT)

Buy Since 17-Sep-2020

$24

$22.12 (1176.60%)

5 months 6 days ago
(10-Apr-2026)

11/12 (91.67%)

$19.06 (385.83%)

526

Please subscribe to see extended stock data

Emily Bodnar (HC WAINWRIGHT)

Buy Since 12-Feb-2024

$25

$23.12 (1229.79%)

5 months 21 days ago
(26-Mar-2026)

14/15 (93.33%)

$20.29 (430.79%)

444

Please subscribe to see extended stock data

Albert Lowe (CRAIG HALLUM)

Buy Since 05-Jun-2025

$2.12 (112.77%)

1 years 3 months 11 days ago
(05-Jun-2025)

1/1 (100%)

$-8.9 (-68.99%)

252

Please subscribe to see extended stock data

Louise Chen (SCOTIABANK)

Buy Since 08-Sep-2023

2 years 2 months 27 days ago
(20-Jun-2024)

1/1 (100%)

$-7.5 (-60.00%)

885

Please subscribe to see extended stock data

Jason Mccarthy (MAXIM GROUP)

Buy Since 11-Oct-2018

$2.06 (41.70%)

5 years 3 months 6 days ago
(10-Jun-2021)

4/4 (100%)

$-54.05 (-88.53%)

1656

Please subscribe to see extended stock data

Show more analysts

Please expand the browser size to see the chart

Which stock is Edward Woo most bullish on?

Potential upside of $53.16 has been obtained for PSTV (PLUS THERAPEUTICS)

Which stock is Edward Woo most reserved on?

Potential downside of $3.44 has been obtained for GNSS (GENASYS)

What Year was the first public recommendation made by Edward Woo?

On 2012